Improving Treatments - Improving Lives

Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis' unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.


May 21, 2015
Conference Call Announcing Interim Report for the first Quarter 2015

PDF Q1 2015 Interim Report
 715.3 KB   Add to Briefcase
PDF Q1 2015 Presentation
 677.7 KB   Add to Briefcase
Webcast Q1 2015 Audiocast
Podcast Q1 2015 MP3 playback version
  11.7 MB   Add to Briefcase

Stock Information